ArticleMolecular neurobiology2026
Calcium Overloading-Induced UBE2O Upregulation Alleviates Neuronal Apoptosis.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Calcium overloading is implicated in the pathogenesis of Alzheimer's Disease (AD) via the activation of calcineurin signaling. Dysregulation of ubiquitin-conjugating enzyme E2 O (UBE2O), an E2-E3 hybrid enzyme, is involved in AD pathogenesis. However, the effect of calcium overloading-mediated calcineurin activation on UBE2O regulation and the role of UBE2O in calcium overloading-induced apoptosis remain elusive. In this study, we aimed to explore the effect of calcium overloading on UBE2O expression and underlying mechanisms, as well as its role in apoptosis. We found that calcium overloading increases the expression of UBE2O in both neuronal and non-neuronal cells, while calcineurin inhibitor alleviates this effect. Moreover, three functional binding sites of MEF2A, a downstream target of calcineurin, are identified within the promoter region of the UBE2O gene. MEF2A facilitates UBE2O promoter activity, as well as its expression at both mRNA and protein levels. Furthermore, increased UBE2O expression attenuates calcium overloading-induced neuronal apoptosis, while reduced UBE2O expression exacerbates calcium overloading-induced neuronal apoptosis. Moreover, neuron-specific overexpression of UBE2O reduced neuronal apoptosis in 5 × FAD mice. This study demonstrated that calcium overloading-induced UBE2O upregulation is mediated by calcineurin-MEF2A signaling pathway, which acts as a protective response to alleviate neuronal apoptosis. It indicates that UBE2O is a potential therapeutic target for neuronal protection in AD.
Indexed as
Identifiers
42371236What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.